Stevanato Group S.p.A. (STVN)
STVNNYSEMedical/Dental Instruments
$13.53
-0.2000 (-1.46%) today
Closed, Nov 10, 4:00 PM ET
- Market cap
- $3.69bn
- P/E
- 19.9
- EPS, last 4 quarters
- $0.6800
- Dividend yield
- –
- Day range
- –
- 52-week range
- $12.05 to $25.45
- Average volume
- –
- Previous close
- $13.73
Analysts
8 coveringBuy4 buy, 4 hold, 0 sell
Targets a year out average $20.50, +51.5% from here
Earnings
next estimate $0.2100Next report
Dec 2025
+5.0%
Mar 2026
+8.3%
Jun 2026
+6.7%
Sep 2026
+5.9%
estimate reported, and the surprise
Financials
| Quarter | Mar 2021 |
|---|---|
| Revenue | $226.66m |
| Gross profit | $76.88m |
| Operating income | $50.47m |
| Net income | $42.98m |
News
8 latest- Stevanato Group S.p.A. Consensus Price Target Decreased by 21.06% to $20.22Fintel · 14 hours ago
- Stevanato Group Q3 Earnings Call HighlightsMarketBeat · 7 days ago
- Stevanato Group S.p.A. Reports Revenue of EUR 326.1 Million for the Three Months Ended September 30, 2026Fintel · 7 days ago
- Stevanato Group S.p.A. Reports Q3 2026 Revenue of 326 Million EurosFintel · 7 days ago
- Stevanato Group S.p.A. Reports 8% Revenue Growth for the Third Quarter of Fiscal 2026Fintel · Nov 3, 2026
- Relative Strength Alert For Stevanato Group BNK Invest · Nov 3, 2026
- Stevanato (STVN) Q3 2026 Earnings Call TranscriptThe Motley Fool · Nov 3, 2026
- Stevanato Group (STVN) Surpasses Q3 Earnings and Revenue EstimatesZacks · Nov 3, 2026
The company
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group's core capabilities in scientific research and development, its commitment to technical innovation, and its engineering excellence are central to its ability to offer value added solutions to clients.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Exchange
- NYSE
- Region
- Europe
- Website
- stevanatogroup.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.